Spherocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Spherocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Spherocytosis surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Spherocytosis surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Spherocytosis surgery

CDC on Spherocytosis surgery

Spherocytosis surgery in the news

Blogs on Spherocytosis surgery

Directions to Hospitals Treating Spherocytosis

Risk calculators and risk factors for Spherocytosis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Overview[edit | edit source]

## Surgery[edit | edit source]

Chronic symptoms of anemia and splenomegaly typically indicate dietary supplementation of iron and eventual treatment by splenectomy, the surgical removal of the spleen.

While splenectomy does not affect the shape of the blood cells, it does remove the more obvious physical symptoms of the disorder, as the blood cells are no longer constantly broken down. Though it offers near-immediate relief from symptoms, splenectomy is often not performed until the patient is in late childhood, so as not to hinder the patient's ability to fight off childhood infections. Currently, the surgery is often performed laparoscopically; this results in a shorter recovery time and a much smaller scar.

Given that surgery is preplanned, it is highly recommended that patients receive prior Pneumovax-II pneumococcus, conjugated-C meningococcus & Haemophilus influenzae type b vaccinations to combat the patient's new lower tolerance against overwhelming post-splenectomy infection. The Pneumovax needs repeating every six years and the patient should have a yearly flu vaccine. Prophylactic antibiotics are also given. (See asplenia for further details on these measures).

## References[edit | edit source]

Template:WH Template:WS